查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888810

兽用眼科药品市场规模、份额和趋势分析报告：按动物、药物、适应症、通路、地区和细分市场预测（2025-2033 年）

Veterinary Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Animal, By Drug, By Indication, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

兽用眼科药品市场摘要

2024年全球兽用眼​​科药品市场规模估计为19.5亿美元，预计2033年将达36亿美元。

预计从 2025 年到 2033 年，该市场将以 7.00% 的复合年增长率成长。推动市场成长的因素包括眼科药物传输技术的进步、长效眼科治疗方法的不断开发、对抗生素管理和循证用药的日益重视，以及对复杂眼科疾病治疗日益增长的临床需求。

药物输送技术的进步正在推动市场成长。耶路撒冷希伯来大学于2025年4月进行的一项研究发现，使用交联玻尿酸（XHA）的眼药水比传统配方效果更佳。具体而言，与使用聚乙烯醇基眼药水的犬隻相比，使用XHA基眼药水的犬隻眼内Cefazolin暴露量高出2.4倍，氯霉素暴露量高出4.2倍。这项改进意义重大，因为更高的药物浓度和更长的眼表停留时间意味着更少的给药次数和更高的宠物饲主依从性。给药负担的减轻提高了高价值眼科药物在兽医领域的吸引力。

此外，2025年4月发表在drug.com网站上的一篇报导进一步支持了这一发现，文章解释说，透明质酸载体可以延长抗生素在犬眼中的持续时间，从而降低抗生素抗药性的风险。值得注意的是，透明质酸本身俱有抗菌特性，并能促进眼部组织的癒合。因此，动物医药生产商看到了开发将抗生素与XHA等先进载体技术结合的眼科製剂的潜力。这些製剂有望提高眼部感染疾病的治疗效果，同时为开发具有类似递送增强效果的新型药物（例如抗真菌药物、免疫调节剂和抗青光眼药物）铺路。

总之，能够提高药物暴露量、减少给药频率并提升疗效的技术正在推动兽用眼科药物的需求成长。兽医诊所更倾向于选择疗效较佳、对饲主刺激性较小的製剂。製造商也透过创新给药系统来应对这一需求，从而推动兽用眼科市场实现更强劲的成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章：兽用眼科药品市场趋势及范围

  • 市场体系展望
    • 母市场
    • 相关市场
  • 市场动态
  • 兽用眼科药品市场分析工具
    • 波特五力分析
    • PESTEL分析（基于SWOT分析）
    • 按地区和主要物种分類的动物数量估计（2024 年）

第四章 兽用眼科药品市场：依动物种类划分，市场规模估算及趋势分析

  • 兽用眼科药品市场：依动物类型分析变化
  • 兽用眼科药品市场规模及依物种分類的趋势（2021-2033 年）
  • 狗
  • 猫
  • 马
  • 牛
  • 其他动物

第五章 兽用眼科药品市场：药物细分、预测及趋势分析

  • 兽用眼科药品市场：依药物分析市场波动
  • 兽用眼科药品市场规模及趋势分析（依药品分类，2021-2033 年）
  • 抗生素
  • 非类固醇消炎剂（NSAIDs）
  • 皮质类固醇
  • 润滑剂/人工泪液
  • 止痛药/止痛剂
  • 其他药物

第六章 兽用眼科药品市场：依适应症分類的估算与趋势分析

  • 兽用眼科药品市场：依适应症分析变化
  • 兽用眼科药品市场规模及趋势分析（依适应症划分，2021-2033 年）
    • 眼睑异常
    • 白内障
    • 青光眼
    • 葡萄膜炎
    • 结膜炎
    • 角膜併发症
    • 其他迹象

第七章 兽用眼科药品市场：依通路分類的估算与趋势分析

  • 兽用眼科药品市场：通路变化分析
  • 兽用眼科药品市场规模及趋势分析（依通路划分）（2021-2033 年）
    • 兽医医院和诊所
    • 专卖店
    • 电子商务
    • 其他分销管道

第八章 兽用眼科药品市场：区域、预测与趋势分析

  • 区域仪錶板
  • 按地区分類的兽用眼科药品市场份额（2024 年和 2033 年）
  • 区域展望
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 卡达
    • 阿曼

第九章 竞争情势

  • 市场参与企业分类
  • 公司市场分析/热力图分析
  • 公司简介
    • Merck &Co., Inc.
    • Zoetis
    • Dechra Pharmaceuticals
    • Virbac
    • Ceva Sante Animale
    • Elanco
    • Bausch &Lomb
    • Sandoz
    • Norbrook Laboratories
    • I-Med Animal Health
Product Code: GVR-4-68040-826-4

Veterinary Ophthalmic Drugs Market Summary

The global veterinary ophthalmic drugs market size was estimated at USD 1.95 billion in 2024 and is projected to reach USD 3.60 billion by 2033, growing at a CAGR of 7.00% from 2025 to 2033. Some of the factors driving the market growth are advancements in ophthalmic drug-delivery technologies, rising development of long-acting ophthalmic therapies, increasing focus on antimicrobial stewardship & evidence-based use, and growing clinical demand for treatment of complex ocular diseases.

Advances in drug-delivery technology are driving market growth. An April 2025 study at the Hebrew University of Jerusalem found that eyedrops using cross-linked hyaluronic acid (XHA) achieved better results than traditional formulations. Specifically, dogs treated with XHA-based drops had 2.4 times greater exposure to cefazolin and 4.2 times greater exposure to chloramphenicol compared to drops using polyvinyl alcohol. This improvement matters because higher drug concentration and longer retention on the ocular surface mean fewer doses and better compliance among pet owners. Lower dosing burden increases the appeal of premium ophthalmic drugs in veterinary practice.

Moreover, another April 2025 drugs.com article confirmed this finding, explaining that the hyaluronic acid carrier allowed antibiotics to stay longer on canine eyes and suggested a reduced risk of antibiotic resistance. It is noted that hyaluronic acid itself has antiseptic properties and supports the healing of eye tissues. As a result, veterinary pharmaceutical firms see an opportunity in developing ophthalmic formulations that combine antibiotics with advanced carriers like XHA. These deliver better outcomes for eye infections and open the door for new categories, such as anti-fungal, immunomodulators, and anti-glaucoma agents with similar delivery enhancements.

To conclude, technology that boosts drug exposure, reduces frequency of dosing, and improves therapeutic effect is pushing demand for veterinary eye-care drugs. Veterinary clinics prefer formulations that work better and require less owner effort. Manufacturers respond by innovating delivery systems. The net effect is stronger growth in the veterinary ophthalmology market.

Global Veterinary Ophthalmic Drugs Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary ophthalmic drugs market report based on animal, drug, indication, distribution channel, and region:

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Feline
  • Equine
  • Bovine
  • Others
  • Drug Outlook (Revenue, USD Million, 2021 - 2033)
  • Antibiotics
  • NSAIDs
  • Corticosteroids
  • Lubricants/Artificial Tears
  • Analgesics/Pain Relievers
  • Others Drugs
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Eyelid Abnormalities
  • Cataract
  • Glaucoma
  • Retinal Complications
  • Uveitis
  • Conjunctivitis
  • Corneal Complications
  • Other Indications
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Specialty Stores
  • E-Commerce
  • Other Distribution Channels
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • India
    • China
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Ophthalmic Drugs Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Advancements in Ophthalmic Drug-Delivery Technologies
      • 3.2.1.2. Rising Development of Long-Acting Ophthalmic Therapies
      • 3.2.1.3. Increasing Focus on Antimicrobial Stewardship & Evidence-Based Use
      • 3.2.1.4. Growing Clinical Demand for Treatment of Complex Ocular Diseases
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Restrictions on Antibiotic Use in Animals
      • 3.2.2.2. Limited Standardized Guidelines for Ophthalmic Antibiotic Prescribing
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Veterinary Ophthalmic Drugs Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis, by SWOT
    • 3.3.3. Estimated Animal Population by region, key species, 2024

Chapter 4. Veterinary Ophthalmic Drugs Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary Ophthalmic Drugs Market: Animal Movement Analysis
  • 4.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
  • 4.4. Canine
    • 4.4.1. Canine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Feline
    • 4.5.1. Feline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Equine
    • 4.6.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Bovine
    • 4.7.1. Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Other Animals
    • 4.8.1. Other Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary Ophthalmic Drugs Market: Drug Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary Ophthalmic Drugs Market: Drug Movement Analysis
  • 5.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by Drug, 2021 to 2033 (USD Million)
  • 5.4. Antibiotics
    • 5.4.1. Antibiotics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. NSAIDs
    • 5.5.1. NSAIDs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Corticosteroids
    • 5.6.1. Corticosteroids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Lubricants/Artificial Tears
    • 5.7.1. Lubricants/Artificial Tears Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Analgesics/Pain Relievers
    • 5.8.1. Analgesics/Pain Relievers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others Drugs
    • 5.9.1. Other Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary Ophthalmic Drugs Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary Ophthalmic Drugs Market: By Indication Movement Analysis
  • 6.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
    • 6.3.1. Eyelid Abnormalities
      • 6.3.1.1. Eyelid Abnormalities Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Cataract
      • 6.3.2.1. Cataract Care Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Glaucoma
      • 6.3.3.1. Glaucoma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.2. Retinal Complications
      • 6.3.3.3. Retinal Complications Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Uveitis
      • 6.3.4.1. Uveitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Conjunctivitis
      • 6.3.5.1. Conjunctivitis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Corneal Complications
      • 6.3.6.1. Corneal Complications Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Other Indications
      • 6.3.7.1. Other Indications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Ophthalmic Drugs Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary Ophthalmic Drugs Market: By Distribution Channel Movement Analysis
  • 7.3. Veterinary Ophthalmic Drugs Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Specialty Stores
      • 7.3.2.1. Specialty Stores Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. E-Commerce
      • 7.3.3.1. E-Commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Other Distribution Channels
      • 7.3.4.1. Other Distribution Channels Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Ophthalmic Drugs Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Veterinary Ophthalmic Drugs Market Share, By Region, 2024 & 2033, USD Million
  • 8.3. Regional Outlook
  • 8.4. North America
    • 8.4.1. North America Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. U.S. Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Canada Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Mexico Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. UK Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Germany Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. France Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Italy Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Spain Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Denmark Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Sweden Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Norway Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Japan Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. China Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. India Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Australia Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. South Korea Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Thailand Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Brazil Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Argentina Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. South Africa Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Saudi Arabia Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. UAE Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Kuwait Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.6. Qatar
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Competitive Scenario
      • 8.8.6.3. Regulatory Framework
      • 8.8.6.4. Qatar Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8.7. Oman
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Competitive Scenario
      • 8.8.7.3. Regulatory Framework
      • 8.8.7.4. Oman Veterinary Ophthalmic Drugs Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Position Analysis/ Heat Map Analysis
  • 9.3. Company Profiles
    • 9.3.1. Merck & Co., Inc.
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Zoetis
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Dechra Pharmaceuticals
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Virbac
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Ceva Sante Animale
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Elanco
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Bausch & Lomb
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Sandoz
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Norbrook Laboratories
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. I-Med Animal Health
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 Veterinary Ophthalmic Drugs Market, by region, 2021 - 2033 (USD Million)
  • Table 3 Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 4 Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 5 Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 6 Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7 North America Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 9 North America Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 10 North America Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 11 North America Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 12 U.S. Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 13 U.S. Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 14 U.S. Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 15 U.S. Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 16 Canada Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 17 Canada Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 18 Canada Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 19 Canada Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 20 Mexico Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 21 Mexico Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 22 Mexico Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 23 Mexico Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 24 Europe Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 25 Europe Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 26 Europe Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 27 Europe Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 28 Europe Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 29 Germany Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 30 Germany Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 31 Germany Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 32 Germany Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 33 UK Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 34 UK Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 35 UK Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 36 UK Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 37 France Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 38 France Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 39 France Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 40 France Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 41 Italy Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 42 Italy Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 43 Italy Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 44 Italy Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 45 Spain Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 46 Spain Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 47 Spain Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 48 Spain Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 49 Denmark Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 50 Denmark Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 51 Denmark Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 52 Denmark Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 53 Sweden Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 54 Sweden Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 55 Sweden Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 56 Sweden Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 57 Norway Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 58 Norway Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 59 Norway Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 60 Norway Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 66 China Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 67 China Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 68 China Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 69 China Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 70 Japan Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 71 Japan Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 72 Japan Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 73 Japan Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 74 India Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 75 India Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 76 India Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 77 India Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 78 South Korea Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 79 South Korea Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 80 South Korea Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 81 South Korea Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 82 Australia Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 83 Australia Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 84 Australia Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 85 Australia Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 86 Thailand Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 87 Thailand Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 88 Thailand Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 89 Thailand Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 90 Latin America Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 92 Latin America Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 93 Latin America Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 94 Latin America Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 95 Brazil Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 96 Brazil Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 97 Brazil Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 98 Brazil Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 99 Argentina Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 100 Argentina Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 101 Argentina Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 102 Argentina Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 103 MEA Veterinary Ophthalmic Drugs Market, by Country, 2021 - 2033 (USD Million)
  • Table 104 MEA Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 105 MEA Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 106 MEA Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 107 MEA Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 108 South Africa Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 109 South Africa Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 110 South Africa Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 111 South Africa Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 116 UAE Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 117 UAE Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 118 UAE Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 119 UAE Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 120 Kuwait Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 124 Qatar Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 125 Qatar Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 126 Qatar Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 127 Qatar Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 128 Oman Veterinary Ophthalmic Drugs Market, by Animal, 2021 - 2033 (USD Million)
  • Table 129 Oman Veterinary Ophthalmic Drugs Market, by Drug, 2021 - 2033 (USD Million)
  • Table 130 Oman Veterinary Ophthalmic Drugs Market, by Indication, 2021 - 2033 (USD Million)
  • Table 131 Oman Veterinary Ophthalmic Drugs Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 132 Company Overview
  • Table 133 Product Benchmarking
  • Table 134 Financial Performance
  • Table 135 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Veterinary Ophthalmic Drugs Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 Veterinary Ophthalmic Drugs Market snapshot
  • Fig. 11 Veterinary Ophthalmic Drugs Market driver impact
  • Fig. 12 Veterinary Ophthalmic Drugs Market restraint impact
  • Fig. 13 Veterinary Eye Care animal key takeaways (USD Million)
  • Fig. 14 Veterinary Ophthalmic Drugs Market: animal, market share 2024 & 2033
  • Fig. 15 Canine market, 2021 - 2033 (USD Million)
  • Fig. 16 Feline market, 2021 - 2033 (USD Million)
  • Fig. 17 Equine market, 2021 - 2033 (USD Million)
  • Fig. 18 Bovine market, 2021 - 2033 (USD Million)
  • Fig. 19 Other Animals market, 2021 - 2033 (USD Million)
  • Fig. 20 Veterinary Ophthalmic Drugs Market Drug key takeaways (USD Million)
  • Fig. 21 Veterinary Ophthalmic Drugs Market: Drug, market share 2024 & 2033
  • Fig. 22 Antibiotics market, 2021 - 2033 (USD Million)
  • Fig. 23 NSAIDs market, 2021 - 2033 (USD Million)
  • Fig. 24 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 25 Lubricants/Artificial Tears market, 2021 - 2033 (USD Million)
  • Fig. 26 Analgesics/Pain Relievers market, 2021 - 2033 (USD Million)
  • Fig. 27 Other Drugs market, 2021 - 2033 (USD Million)
  • Fig. 28 Veterinary Ophthalmic Drugs Market, by Indication: Key takeaways
  • Fig. 29 Veterinary Ophthalmic Drugs Market, by Indication, market share, 2024 & 2033
  • Fig. 30 Eyelid Abnormalities market, 2021 - 2033 (USD Million)
  • Fig. 31 Cataract market, 2021 - 2033 (USD Million)
  • Fig. 32 Glaucoma market, 2021 - 2033 (USD Million)
  • Fig. 33 Retinal Complications market, 2021 - 2033 (USD Million)
  • Fig. 34 Uveitis market, 2021 - 2033 (USD Million)
  • Fig. 35 Conjunctivitis market, 2021 - 2033 (USD Million)
  • Fig. 36 Corneal Complications market, 2021 - 2033 (USD Million)
  • Fig. 37 Other Indications market, 2021 - 2033 (USD Million)
  • Fig. 38 Veterinary Ophthalmic Drugs Market, by Distribution Channel: Key takeaways
  • Fig. 39 Veterinary Ophthalmic Drugs Market, by Distribution Channel, market share, 2024 & 2033
  • Fig. 40 Veterinary Hospitals & Clinics market, 2021 - 2033 (USD Million)
  • Fig. 41 Specialty Stores market, 2021 - 2033 (USD Million)
  • Fig. 42 E-Commerce market, 2021 - 2033 (USD Million)
  • Fig. 43 Other Distribution Channels market, 2021 - 2033 (USD Million)
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 Regional outlook, 2024 & 2033
  • Fig. 46 North America Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 47 U.S. Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 48 Canada Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 49 Mexico Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 50 Europe Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 51 UK Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 52 Germany Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 53 France Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 54 Italy Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 55 Spain Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 56 Denmark Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 57 Sweden Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 58 Norway Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 59 Asia Pacific Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 60 Japan Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 61 China Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 62 India Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 63 Australia Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 64 South Korea Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 68 Argentina Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 69 MEA Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 70 South Africa Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 71 Saudi Arabia Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 72 UAE Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 73 Kuwait Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 74 Qatar Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 75 Oman Veterinary Ophthalmic Drugs Market, 2021 - 2033 (USD Million)
  • Fig. 76 Market participant categorization